Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3772-3778

  Kong, Xiao Tang ^a   Choi, Seung Hoon ^b   Inoue, Akira ^c   Xu, Feng ^a   Chen, Tao ^a   Takita, Junko ^d   Yokota, Jun ^d   Bessho, Fumio ^a   Yanagisawa, Masayoshi ^a   Hanada, Ryoji ^e   Yamamoto, Keiko ^e   Hayashi, Yasuhide ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d NATIONAL CANCER CENTER RESEARCH INSTITUTE   (Japan)

^e SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CHROMOSOME 18Q; CLINICAL ARTICLE; DNA POLYMORPHISM; EXON; GENE ACTIVATION; GENE EXPRESSION; GENE MUTATION; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; INFANT; MISSENSE MUTATION; NEUROBLASTOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SINGLE STRAND CONFORMATION POLYMORPHISM; SOUTHERN BLOTTING; TUMOR SUPPRESSOR GENE;

CELL ADHESION MOLECULES; CHILD; CHILD, PRESCHOOL; DNA-BINDING PROTEINS; EXONS; FEMALE; GENE EXPRESSION; GENES, DCC; GENES, TUMOR SUPPRESSOR; HUMANS; INFANT; INFANT, NEWBORN; MALE; MUTATION; NEOPLASM PROTEINS; NEOPLASM STAGING; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; RECEPTORS, CELL SURFACE; RNA, MESSENGER; SMAD2 PROTEIN; SMAD4 PROTEIN; TRANS-ACTIVATORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEINS;

EID: 14444275781     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Vogelstein, B., Fearon, E., Kern, S., Hamilton, S., Preisinger, A., Nakamura, Y., and White, R. Allelotype of colorectal carcinomas. Science (Washington DC), 244: 207-211, 1989.
2. Huang, Y., Boynton, R. F., Blount, P. L., Silverstein, R. J., Yin, Y., Tong, Y., McDaniel, T. K., Newkirk, C., Resau, J. H., Sridhara, R., Reid, B. J., and Meltzer, S. J. Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res., 52: 6525-6530, 1992.
3. Cliby, W., Ritland, S., Hartmann, L., Dodson, M., Halling, K. C., Keeney, G., Podrats, K. C., and Jenkins, R. B. Human epithelial ovarian cancer allelotype. Cancer Res., 53: 2393-2398, 1993.
4. Brewster, S. F., Gingell, J. C., Browne, S., and Brown, K. W. Loss of heterozygosity on chromosome 18q is associated with muscle-invasive transitional cell carcinoma of the bladder. Br. J. Cancer, 70: 697-700, 1994.
5. Shibagaki, I., Shimada, Y., Wagata, T., Ikenaga, M., Imamura, M., and Ishigaki, K. Allelotype analysis of esophageal squamous cell carcinoma. Cancer Res., 54: 2995-3000, 1994.
6. Shiseki, M., Kohno, T., Nishikawa, R., Sameshima, Y., Mizoguchi, H., and Yokota, J. Frequent allelic losses on chromosomes 2q, 18q, and 22q in advanced non-small cell lung carcinoma. Cancer Res., 54: 5643-5648, 1994.
7. Hahn, S. A., Seumour, A. B., Hoque, A. T. M. S., Schutte, M., da Costa, L. T., Redston, M. S., Caldas, C., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. Allelotype of pancreatic adenocarcinoma using xenograft enrichment. Cancer Res., 55: 4670-4675, 1995.
8. Takita, J., Hayashi, Y., Kohno, T., Shiseki, M., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Allelotype of neuroblastoma. Oncogene, 11: 1829-1834, 1995.
9. Fearon, E. R., Cho, K. R., Nigro, J. M., Kern, S. E., Simons, J. W., Ruppert, J. M., Hamilton, S. R., Preisinger, A. C., Thomus, G., Kinzler, K. W., and Vogelstein, B. Identification of a chromosome 18q gene that is altered in eolorectal cancers. Science (Washington DC), 247: 49-56, 1990.
10. Hahn, S. A., Schutte, M., Hoque, A. T. M. S., Moskaluk, C. A., da Costa, L. T., Rozenblum, E., Weinstein, C. L., Fischer, A., Yeo, C. J., Hruban, R. H., and Kern, S. E. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science (Washington DC), 271: 350-353, 1996.
11. Eppert, K., Scherer, S. W., Ozcelik, H., Pirone, R., Hoodless, P., Kim, H., Tsui, L-C., Bapat, B., Gallinger, S., Andrulis, I. L., Thomsen, G. H., Wrana, J. L., and Attisano, L. MADR2 maps to 18q21 and encodes a TGFβ-regulated MAD-related protein that is functionally mutated in colorectal carcinoma. Cell, 86: 543-552, 1996.
12. Riggins, G. J., Thiagalingam, S. R., Rozenblum, E., Weinstein, C. L., Kern, S. E., Hamilton, S. R., Wilson, J. K. V., Markowitz, S. D., Kinzler, K. W., and Vogelstein, B. Mad-related genes in the human. Nat. Genet., 13: 347-349, 1996.
13. Kikuchi-Yanoshita, R., Konishi, M., Fukunari, H., Tanaka, K., and Miyaki, M. Loss of expression of the DCC gene during progression of colorectal carcinomas in familial adenomatous polyposis and non-familial adenomatous polyposis patients. Cancer Res., 52: 3801-3803, 1992.
14. Itoh, F., Hinoda, Y., Ohe, M., Ban, T., Endo, T., Imai, K., and Yachi, A. Decreased expression of DCC mRNA in human colorectal cancers. Int. J. Cancer, 53: 260-263, 1993.
15. Ookawa, K., Sakamoto, M., Hirohashi, S., Yoshida, Y., Sugimura, T., Terada, M., and Yokota, J. Concordant p53 and DCC alterations and allelic losses on chromosomes 13q and 14q associated with liver metastases of colorectal carcinoma. Int. J. Cancer, 53: 382-387, 1993.
16. Shibata, D., Reale, M. A., Lavin, P., Silverman, M., Fearon, E. R., Steele, G., Jessup J. M., Load, M., and Summerhayes, I. C. The DCC protein and prognosis in colorectal cancer. N. Engl. J. Med., 335: 1727-1732, 1996.
17. Cho, K. R., and Fearon, E. R. DCC. Linking tumor suppressor genes and altered cell surface interactions in cancer? Eur. J. Cancer, 31A: 1055-1060, 1995.
18. Enomoto, T. Fujita, M., Cheng, C., Nakashima, R., Ozaki, M., Inoue, M., and Nomura, T. Loss of expression and loss of heterozygosity in the DCC gene in neoplasms of the human female reproductive tract. Br. J. Cancer, 71: 462-467, 1995.
19. Miyake, S., Nagai, K., Yoshino, K., Oto, M., Endo, M., and Yuasa, Y. Point mutations and allelic deletion of tumor suppressor gene DCC in human esophageal squamous cell carcinomas and their relation to metastasis. Cancer Res., 54: 3007-3010, 1994.
20. Reale, M. A., Reyes-Mugica, M., Pierceall, W. E., Rubinstein, M. C., Hedrick, L., Cohn, S. L., Nakagawara, A., Brodeur, G. M., and Fearon, E. R. Loss of DCC expression in neuroblastomas is associated with disease dissemination. Clin. Cancer Res., 2: 1097-1102, 1996.
21. Reyes-Mugica, M., Rieger-Christ, K., Ohgaki, H., Ekstrand, B. C., Helie, M., Kleinman, G., Yahanda, A., Fearon, E. R., Kleihues, P., and Reale, M. A. Loss of DCC expression and glioma progression. Cancer Res., 57: 382-386, 1997.
22. Cho, K. R., Oliner, J. D., Simons J. W., Hedrick, L., Fearon, E. R., Preisinger, A. C., Hedge, P., Silverman, G. A., and Vogelstein, B. The DCC gene: structure analysis and mutations in colorectal carcinomas. Genomics, 19: 525-531, 1994.
23. Hedrick, L., Cho, K. R., Fearon, E. R., Wu, T-C., Kinzler, K. W., and Vogelstein, B. The DCC gene product in cellular differentiation and colorectal tumorigenesis. Genes Dev., 8: 1174-1183, 1994.
24. Reale, M. A., Hu, G., Zafar, A. I., Getzenherg, R. H., Levine S. M., and Fearon, E. R. Expression and alternative splicing of the deleted in colorectal cancer (DCC) gene in normal and malignant tissues. Cancer Res., 54: 4493-4501, 1994.
25. Kolodziej, P. A., Timpe, L. C., Mitchell, K. J., Fried, S. R., Goodman, C. S., Jan, L. Y., and Jan, Y. N. frazzled encodes a Drosophila member of the DCC immunoglobulin subfamily and is required for CNS and motor axon guidance. Cell, 87: 197-204, 1996.
26. Chan, S. S-Y., Zheng, H., Su, M-W., Wilk, R., Killeen, M. T., Hedgecock, E. M., and Culotti, J. G. UNC-40, a C. elegans homolog of DCC (deleted in colorectal cancer), is required in motile cells responding to UNC-6 netrin cues. Cell, 87: 187-195, 1996.
27. Vielmetter, J., Kayyem, J. F., Roman, J. M., and Dreyer, W. J. Neogenin, an avian cell surface protein expressed during terminal neuronal differentiation, is closely related to the human tumor suppressor molecule deleted in colorectal cancer. J. Cell Biol., 127: 2009-2020, 1994.
28. Lawlor, K. G., and Narayanan, R. Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth & Differ., 3: 609-616, 1992.
29. Pierceall, W. E., Cho, K. R., Getzenberg, R. H., Reale, M. A., Hedrick, L., Vogelstein, B., and Fearon, E. R. NIH3T3 cells expressing the deleted in colorectal cancer tumor suppressor gene product stimulate neunte outgrowth in rat PC12 pheochromocytoma cells. J. Cell Biol., 124: 1017-1027, 1994.
30. Masu-Keino, K., Masu, M., Hinck, L., Leonardo, E. D., Chan, S. S-Y., Culotti, J. G., and Tessier-Lavigne, M. Deleted in calorectal cancer (DCC) encodes a netrin receptor. Cell, 87: 175-185, 1996.
31. Tanaka, K., Oshimura, M., Kikuchi, R., Seki, M., Hayashi, T., and Miyaki, M. Suppression of tumorigenicity in human colon carcinoma cells by introduction of normal chromosome 5 or 18. Nature (Lond.), 349: 340-342, 1991.
32. Narayanan, R., Lawlor, K. G., Schaapvel, R. Q., Cho, K. R., Vogelstein, B., Tran, P. B-V., Oshome, M. P., and Telang, N. T. Antisense RNA to the putative tumor suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene, 7: 533-561, 1992.
33. Klingelhutz, A. J., Hedrick, L., Cho, K. R., and McDougall, J. K. The DCC gene suppresses the malignant phenotype of transformed human epithelial cells. Oncogene, 10: 1581-1586, 1995.
34. Massagué, J. TGFβ signaling: receptors, transducers and Mad proteins. Cell, 85: 947-950, 1996.
35. Nagatake, M., Takagi, Y., Osada, H., Uchida, K., Mitsudomi, T., Saji, S., Shimokata, K., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the DPC4 gene at 18q21 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
36. Barrett, M. T., Schutte, M., Kern, S. E., and Reid, B. J. Allelic loss and mutational analysis of the DPC4 gene in esophageal adenocarcinoma. Cancer Res., 56: 4351-4353, 1996.
37. Schutte, M., Hruban, R. H., Hedrick, L., Cho, K. R., Nadasdy, G. M., Weinstein, C. L., Bova, G. S., Isaacs, W. B., Cairns, P., Nawroz, H., Sidransky, D., Casero, R. A., Meltzer, P. S., Hahn, S. A., and Kern, S. E. DPC4 gene in various tumor types. Cancer Res., 56: 2527-2530 1996.
38. Kim, S. K., Fan, Y., Papadimitrakopoulou, V., Clayman, G., Hittelman, W. N., Hong, W. K., Lotan, R., and Mao, L. DPC4, a candidate tumor suppressor gene, is altered infrequently in head and neck squamous cell carcinoma. Cancer Res., 56: 2519-2521, 1996.
39. Uchida, K., Nagatake, M., Osada, H., Yatabe, Y., Kondo, M., Mitsudomi, T., Masuda, A., Takahashi, T., and Takahashi, T. Somatic in vivo alterations of the JV18-1 gene at 18q21 in human lung cancers. Cancer Res., 56: 2718-2720, 1996.
40. Bessho, F. Effects of mass screening on age-specific incidence of neuroblastoma. Int. J. Cancer, 67: 520-522, 1996.
41. Hayashi, Y., Kanda, N., Inaba, T., Kanada, R., Nagahara, N., Muchi, H., and Yamamoto, K. Cytogenetic findings and prognosis in neuroblastoma with emphasis on marker chromosome 1. Cancer (Phila.), 63: 126-132, 1989.
42. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E., and Brodeur, G. M. Loss of heterozygosity for the short arm of chromosome 1 in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
43. Srivatsan, E. S., Ying, K. L., and Seeger, R. C. Deletion of chromosome 11 and 14q sequences in neuroblastoma. Genes Chromosomes Cancer, 7: 32-37, 1993.
44. Suzuki, T., Yokota, J., Mugishima, H., Okabe. I., Ookuni, M., Sugimura, T., and Terada, M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res., 49: 1095-1098, 1989.
45. Brodeur, G. M., Seeger, R. C., Schwab, M., Varmus, H. E., and Bishop, J. M. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science (Washington DC), 224: 1121-1124, 1984.
46. Seeger, R. C., Brodeur, G. M., Sather, H., Dalton, A., Siegel, S. E., Wong, K. Y., and Hammond, D. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas. N. Engl. J. Med., 313: 1111-1116, 1985.
47. Hayashi, Y., Hanada, R., Moriwaki, K., Yamamoto, K., Imaizumi, S., Hirata, A., and Nishida, T. Establishment and characterization of cell lines derived from malignant tumors in children. J. Saitama Child. Med. Ctr., 8: 17-23, 1991 (in Japanese).
48. Komuro, H., Hayashi, Y., Kawamura, M., Hayashi, K., Kaneko, Y., Kamoshita, S., Hanada, R., Yamamoto, K., Hongo, T., Yamada, M., and Tsuchida, Y. Mutations of the p53 gene are involved in Ewing's sarcomas but not in neuroblastomas. Cancer Res., 53: 5284-5288, 1993.
49. Evans, A. E., D'Angio, G. J., and Randolph, J. A proposed staging for children with neuroblastoma. Children's cancer study group A. Cancer (Phila.), 27: 374-378, 1971.
50. Hayashi, Y., Hanada, R., and Yamamoto, K. Biology of neuroblastoma in Japan found by screening. Am. J. Pediatr. Hematol. Oncol., 14: 342-347, 1992.
51. Sawaguchi, S., Kaneko, M., Uchino, J., Takeda, T., Iwafuchi, M., Matsuyama, S., Takahashi, H., Nakajo, T., Hoshi, Y., Okabe, I., Yokoyama, J., Nishihira, H., Sakaki, S., Sakurai, M., Sawada, T., Nagahara, N., and Tsuchida, Y. Treatment of advanced neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Study Group of Japan. Cancer (Phila.), 66: 1879-1887, 1990.
52. Chomczynski, P., and Sacchi, N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem., 162: 156-159, 1987.
53. Ida, K., Kobayashi, S., Taki, T., Hanada, R., Bessho, F., Yamamori, S., Sugimoto, T., Ohki, M., and Hayashi, Y. EWS-FLI-1 and EWS-ERG chimeric in RNAs in Ewing's sarcoma and primitive neuroectodermal tumor. Int. J. Cancer, 63: 500-504, 1995.
54. Ponte, P., Ng, S. Y., Engel, J., Gunning, P., and Kedes, L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human β-actin cDNA. Nucleic Acids Res., 12: 1687-1696, 1984.
55. Fearon, E. R., and Vogelstein, B. A genetic model for colorectal tumorigenesis. Cell, 61: 759-767, 1990.
56. Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E., Burger, P. C., Baylin, S. B., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
57. Takita, J., Hayashi, Y., Kohno, T., Yamaguchi, N., Hanada, R., Yamamoto, K., and Yokota, J. Deletion map of chromosome 9 and p16 (CDKN2A) gene alterations in neuroblastoma. Cancer Res., 57: 907-912, 1997.
58. Ekstrand, B. C., Mansfield, T. A., Bigner, S. H., and Fearon, E. R. DCC expression is altered by multiple mechanisms in brain tumors. Oncogene, 11: 2393-2402, 1995.